Eigen Therapeutics Inc.

Biotechnology

Overview

Eigen is a biotechnology company developing therapies that make cancer easier to find and eliminate. Eigen is focused on the development of.

Funding and backers

Backers
1
First Round Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Honeycomb InsuranceSeries B $36M · 2 yr ago · 51-200 employees · 10 roles
At Honeycomb Insurance we're simplifying the real estate insurance process, making it easier to find better coverage at a fraction of the…
KyraFounded 2017 · 201-500 employees · 18 roles
Learn about Kyra's mission to make influencer marketing smarter, more effective, and easier to scale. Founded in 2017.
HiberCellVenture round $60M · 7 yr ago · 51-200 employees
Developing therapies targeting adaptive-stress driven vulnerabilities to combat treatment resistance, cancer relapse, and metastasis.
Draupnir BioSeed $13M · 2 yr ago
Draupnir Bio is developing new innovative therapies for patients.
Epicrispr BiotechnologiesSeries C $90M · 2 mo ago · 201-500 employees
Home. Developing therapies to dynamically control gene expression and treat complex disease.
IMINVenture round · 4 mo ago · Founded 2021
Make every activity easier to find, book, and fill. imin builds the data infrastructure and operations tools for the leisure and fitness…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
189 portfolio companies: Zefr, Phonic, Xclaim and 186 more